CMR Molecular Imaging Announces the Installation of a Breast PET Imaging System in Egypt
CMR Molecular Imaging reached an agreement with Alfa Scan for the installation of the first high-resolution dedicated Breast PET System in Egypt.
CARLSBAD, Calif., July 11, 2019 /PRNewswire-PRWeb/ -- CMR Molecular Imaging, a developer and manufacturer of technology solutions for high resolution diagnostic imaging, has reached an agreement with Alfa Scan, an organization specializing in medical imaging and development, to provide a Solo II™ High Resolution Breast PET Imaging (BPI) System with biopsy guidance capabilities. The transaction was closed by CMR local representative Global Technologies, a leading provider of healthcare equipment in Egypt.
The Solo II High Resolution PET system provides metabolic visualization of lesions in small body parts. Through a unique combination of gentle immobilization, advanced photonics and imaging processing, the scanner provides tomographic images with a resolution as small as 1.6 mm. The Stereo Navigator® PET Guided Biopsy Accessory, the only FDA cleared PET biopsy guidance device, confirms a biopsy path with a 3-D needle trajectory image that enables physicians to target and guide biopsy devices to obtain adequate tissues samples for pathologic evaluation.
"Our primary concern is to provide our patients with the highest possible quality of care. The incorporation of the Solo II Breast PET Imaging System will enable our physicians to solve many diagnostic problems and early detection of breast cancer, especially in women with dense breast and /or unfit for breast MRI, by providing more specific information based on molecular imaging and will help them to plan the treatment and monitoring of breast cancers" said Dr. Amr Osama Azab, Managing Director, Alfa Scan
"We at CMR are honored to have been selected by Alfa Scan as suppliers of breast PET technology that will significantly improve cancer detection and treatment for their patients" said Dr. Jenny Matsiota, CMR Molecular Imaging International Business Development Manager.
About CMR Molecular Imaging: CMR Molecular Imaging, a unit of CMR Naviscan Corporation, a leader in organ-specific molecular imaging and part of the Compañia Mexicana de Radiologia CGR, S.A. de C.V. (CMR), a global developer and manufacturer of high quality diagnostic imaging equipment and healthcare information systems, including DICOM-compliant imaging software. CMR Naviscan, headquartered in Carlsbad, California, develops and manufactures molecular imaging systems, including the Solo II™ High Resolution Breast PET Imaging (BPI) scanner, , the Stereo Navigator® Accessory, and the LumaGEM® Molecular Breast Imaging (MBI) system. CMR Naviscan is US FDA registered and ISO 13485:2012 certified. For more information visit http://www.cmr-naviscan.com/.
About Alfa Scan: Alfa Scan is an organization dedicated to improve the quality of healthcare by investing in modern technology and human resources. Established in 1996, it provides advanced imaging information with state of the art diagnostic and interventional radiology systems and it is staffed with fully certified physicians, specialists, subspecialists, physicists, technologists and support personnel that make patient care their highest priority. Alfa Scan had the privilege to be the first to adopt the latest technologies in diagnostic and interventional radiology and was the first to introduce PET/CT in Egypt in a private equity in 2009. Currently there are five major branches for Alfa Scan, located in Mohandesin, Heliopolis, Maadi, ElSheik Zayed city and fifth settlement " New Cairo" regions in Greater Cairo. For more information visit https://www.alfascan.com.eg/ .
SOURCE CMR Molecular Imaging
Share this article